NCT02010944View on ClinicalTrials.gov

A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Phase 1BioavailabilityHealthy Subjects

Interventions

DRUG

solifenacin succinate

oral

DRUG

mirabegron

oral

DRUG

mirabegron/solifenacin succinate

oral

Trial Locations (1)

14050

Parexel, Berlin

All Listed Sponsors

lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT02010944 - A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels | Biotech Hunter | Biotech Hunter